Ambient AI Scribes in the ED: A Governance Checklist Before You Let the Note Drive the Care

Ambient AI Scribes in the ED: A Governance Checklist Before You Let the Note Drive the Care

If you’ve ever reviewed a chart the next day and thought, “That’s not what happened,” you already understand the core risk of ambient AI documentation.

It’s not that the tool will occasionally miss a word.

It’s that the note will look polished enough to be believed — by you, by consultants, by risk management, by the plaintiff’s attorney — even when it’s wrong.

Ambient AI scribes are arriving in emergency departments because they solve a real problem: cognitive overload plus documentation burden. I’m not anti-scribe. I’m anti-un-governed scribe.

What follows is the operational checklist I’d want in place before an ED lets an ambient AI system write clinical documentation at scale. Not because the technology is evil. Because the workflow is high stakes, the incentives are misaligned, and the failure mode is quiet.

Why this matters in emergency medicine (and why the risk is different)

Emergency documentation is not a diary. It is a clinical control surface.

The note doesn’t just memorialize decisions — it creates downstream decisions:

• It drives consultant behavior (“This sounds like cellulitis.”)
• It drives admission vs discharge arguments
• It shapes radiology reads when the history is pre-loaded
• It becomes the durable artifact that other clinicians anchor on

When the note is wrong, the downstream care gets nudged in the wrong direction. And in the ED, nudges matter.

AHRQ has been blunt about the diagnostic-safety risk: AI-generated notes can be “inaccurate, inconsistent, and biased,” and that can directly contribute to diagnostic error (AHRQ).

The failure modes you have to plan for (before go-live)

Here are the ways ambient AI documentation breaks in real ED conditions. Not theory. Shift reality.

1) Confident hallucination: the “polished lie”

A human scribe makes typos and obvious gaps. An LLM makes a complete-sounding paragraph.

That’s the danger. If a note reads smoothly, we stop interrogating it.

What it looks like:

• ROS populated with negatives that weren’t asked
• “Patient denies…” statements that never occurred
• A clean timeline that compresses messy ED reality

Operational countermeasure:

• Require a visible “AI generated / clinician verified” indicator in the note header.
• Require a hard attestation step: “I verified HPI, MDM, and discharge instructions.”
• Sample 20 notes/week for hallucination patterns and feed them back as training/optimization tickets.

2) Quote laundering and tone distortion

Ambient systems often summarize instead of quoting. That changes meaning.

Example:

• Patient says: “I’m scared I’m having a stroke.”
• Note says: “Patient anxious.”

Operational countermeasure:

• In high-risk complaints (CP, neuro deficit, SOB, abdominal pain, pregnancy, pediatrics), require a short verbatim patient quote field.

3) Template drift: the system learns the wrong habits

EDs are already template factories. Ambient AI can quietly reinforce the worst versions:

• autopopulated “normal” exams
• generic differentials that don’t match the patient
• MDM that reads like defensive billing copy

Operational countermeasure:

• Prohibit auto-import of a “complete exam” unless it was actually performed and edited.
• Make the system show what data it used (audio segments, structured vitals, orders, timestamps) so you can audit provenance.

4) Documentation becomes a clinical decision engine (without being regulated like one)

This is the part administrators miss.

A tool marketed as “documentation support” can still drive clinical management by shaping what gets communicated, what gets emphasized, and what gets omitted.

From a regulatory lens, FDA describes a global Software as a Medical Device (SaMD) risk framework that classifies software based on the state of the condition (critical/serious/non-serious) and the significance of the information to the decision (treat/diagnose vs drive vs inform clinical management) (FDA).

I’m not arguing every ambient scribe is SaMD. I’m saying: if the note is steering care, your governance needs to look more like a clinical tool review than an IT rollout.

Operational countermeasure:

• Treat ambient documentation as part of the ED’s clinical AI inventory.
• Put a physician owner on it, not just informatics.

The governance checklist (print this and make someone accountable)

If you’re leading an ED rollout, here’s the checklist. If your vendor can’t support these items, you are not buying a solution — you’re buying risk.

1) Ownership and escalation

• Named physician owner (not a committee).
• Named operational owner (ED nurse manager/ops).
• Clear “pause the system” authority.
• Defined escalation path for frontline clinicians: one-click report, tracked like a patient-safety event.

2) Scope of use

• Which note types are allowed? (low-acuity? fast track? trauma? psych?)
• Which complaints are excluded at go-live?
• Is the tool allowed to generate discharge instructions?
• Does it touch medical decision making language or only HPI?

3) Data handling and consent

• Patient-facing disclosure language.
• Recording rules (audio retention, deletion, who can access).
• How the system handles sensitive conversations (sexual assault, domestic violence, minors, psych).

4) Quality assurance (QA) that’s real, not performative

• Define what “good” looks like (accuracy, completeness, bias checks, medicolegal defensibility).
• Weekly QA sampling with clinician reviewers.
• A structured “error taxonomy” (hallucination, omission, wrong timeline, wrong exam, wrong meds, wrong quote).
• Vendor SLA for fixes and model updates.

5) Bias and subgroup review

If the tool is “inaccurate, inconsistent, and biased,” you won’t discover it by reading random notes (AHRQ).

You discover it by looking where healthcare already fails:

• limited English proficiency
• mental health complaints
• intoxication
• dementia / delirium
• homelessness

Make subgroup review part of the go-live plan.

6) Downtime and failure mode drills

Assume the system will be unavailable on the worst day. Because it will.

• What is the failover workflow?
• What happens if audio capture fails mid-encounter?
• What happens if it outputs nonsense?
• Who tells the department to stop using it?

Dr. Chet’s Take

Ambient AI scribes are going to help a lot of physicians survive the cognitive load of modern emergency medicine. That’s the upside.

But if your department rolls one out like a normal IT feature — “train the staff, flip the switch, move on” — you will end up with notes that are believable, wrong, and legally radioactive.

The fix is not fear. The fix is governance:

• ownership
• scope limits
• QA with teeth
• an easy way to report failures
• permission to override the system socially and operationally

If your hospital leadership wants ambient AI, good. Tell them yes — and hand them this checklist.

Key Takeaways

• Ambient AI documentation can reduce burden, but it introduces a new diagnostic-safety risk: polished, confident inaccuracies (AHRQ).
• In the ED, documentation isn’t passive; it drives downstream decisions and anchoring.
• Treat ambient documentation like a clinical AI tool: define ownership, limits, QA, and escalation pathways.
• Build subgroup review into the rollout or you’ll automate existing blind spots.
• Plan downtime and failure mode drills before go-live.

FAQ

1) Are ambient AI scribes safe to use in the ED? They can be, but only with real governance: scope limits, QA review, and a clear ability to pause the system when it misbehaves.

2) What’s the single highest-risk failure mode? The believable wrong note — a polished narrative that contains inaccuracies clinicians don’t catch because it reads well.

3) Should the AI write the medical decision making (MDM) section? At most sites, I’d start by restricting it. Let it draft HPI, then earn its way into MDM only after you have evidence it doesn’t distort timelines, risk statements, or differential reasoning.

4) How do we prevent bias in AI-generated notes? You won’t prevent it with good intentions. You prevent it with subgroup audits and structured review — especially in populations where communication is challenging or clinicians already anchor incorrectly.

5) Does the FDA regulate ambient AI scribes? Regulatory status depends on intended use and how the software influences clinical decisions. The FDA’s SaMD framework categorizes risk based on condition severity and whether software output treats/diagnoses, drives, or informs clinical management (FDA).

Lead Magnet

If you're an emergency physician (or any clinician treating patients daily) trying to understand how AI will actually impact your clinical practice -- not just the hype -- I put together a free practical guide. You can download it here: AI in EM Survival Guide

Read more from Dr. Shermer on Medium: Read more from Dr. Shermer on Medium

Sources

• AHRQ – The Future of Diagnostic Documentation: https://www.ahrq.gov/diagnostic-safety/resources/issue-briefs/dxsafety-ehr-impact5.html
• FDA – Global Approach to Software as a Medical Device: https://www.fda.gov/medical-devices/software-medical-device-samd/global-approach-software-medical-device